High mobility group box protein 1 (HMGB1) is a ubiquitous nuclear protein released by glia
and neurons upon inflammasome activation and activates receptor for advanced glycation …

One increasingly documented tendency of COVID-19 patients is to exhibit neuropsychiatric
and neurological symptoms. Here we found that anxiety and cognitive impairment are …

Introduction Focal cortical dysplasia (FCD) is a common cause of pharmacoresistant epilepsy.
According to the 2022 International League Against Epilepsy classification, FCD type II is …

Although post-acute cognitive dysfunction and neuroimaging abnormalities have been
reported after hospital discharge in patients recovered from COVID-19, little is known about …

Although some studies have shown neuroimaging and neuropsychological alterations in
post-COVID-19 patients, fewer combined neuroimaging and neuropsychology evaluations of …

Hippocampal sclerosis (HS) is a common cause of pharmacoresistant focal epilepsy. Here,
we (1) performed a histological approach to the anterior temporal pole of patients with HS to …

Introduction: Epilepsy affects 1% to 2% of the world population and temporal lobe epilepsy
associated with hippocampal sclerosis (TLE-HS) is the most common epilepsy in adults. …

Focal cortical dysplasia (FCD) is a common cause of pharmacoresistant epilepsy.
According to the 2022 International League Against Epilepsy classification, FCD type II is …

The rapid and constant development of deep learning (DL) strategies is pushing forward the
quality of object segmentation in images from diverse fields of interest. In particular, these …

Background Although several studies have emphasized the association between epilepsy
and psychiatric disorders, fewer have investigated the impact of epilepsy on caregivers' …